Ensysce Biosciences, Inc.

NasdaqCM: ENSC · Healthcare

Positivity Index

#6,560 / 6,774

Global

#3,804 / 4,000

United States

Positivity Score

-25,200

Rank→

PosiRed: 2 active red flags (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 22 May 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 27 Feb 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

Ensysce Biosciences, Inc. — Overview & Financial Snapshot

Ensysce Biosciences, Inc. (NasdaqCM: ENSC) is a Healthcare company, ranked #6,560 of 6,774 companies globally and #3,804 of 4,000 in United States on PositoAI, with a Positivity Score of -25,200. Its market capitalisation is ₹93.85 Cr ($9.94M), P/E ratio is -0.2 and P/B ratio is -12.72. It currently has 2 active red flags (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

What does Ensysce Biosciences, Inc. do?

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when…

What is Ensysce Biosciences, Inc.'s P/E and P/B ratio?

Ensysce Biosciences, Inc. has a P/E ratio of -0.2 and a P/B ratio of -12.72.

What is Ensysce Biosciences, Inc.'s debt-to-equity ratio?

Ensysce Biosciences, Inc. has a debt-to-equity ratio of 0.10.

How much does Ensysce Biosciences, Inc. owe compared with what it owns?

Ensysce Biosciences, Inc. owes $1.38 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.

What is Ensysce Biosciences, Inc.'s Positivity rank?

Ensysce Biosciences, Inc. is ranked #6,560 of 6,774 companies globally and #3,804 of 4,000 in United States on PositoAI, with a Positivity Score of -25,200.

Does Ensysce Biosciences, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. Ensysce Biosciences, Inc. has 2 active red flags (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 22 May 2026); Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 27 Feb 2026). It has no yellow flags.

Where can I read the latest news about Ensysce Biosciences, Inc.?

Recent headlines about Ensysce Biosciences, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Ensysce Biosciences, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Ensysce Biosciences, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.